Home・Aandelen Lijst・Abbott Laboratories

Abbott Laboratories

Gesloten

SectorGezondheidszorg

105.76 -0.96

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

104.4

Max

107.31

Belangrijke statistieken
By Trading Economics
Inkomsten	-699M 1.1B
Verkoop	1.4B 13B
K/W Sectorgemiddelde	33.383 64.641
EPS	1.31
Dividendrendement	2.41
Winstmarge	9.647
Werknemers	122,000
EBITDA	-465M 1.8B

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+12.16% upside

Dividenden
By Acuity
Dividendrendement Sectorgemiddelde	2.41% 2.31%
Volgende Winsten	14 okt 2026
Volgende dividenddatum	17 aug 2026
Volgende Ex Dividend datum	14 okt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	16B 180B
Vorige openingsprijs	106.72
Vorige sluitingsprijs	105.76

Nieuwssentiment

By Acuity

21%

79%

48 / 340 Rangschikking in Healthcare

Abbott Laboratories Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 aug 2026, 23:06 UTC

Abbott Laboratories shares are near unchanged in after-market trading, positioned 7.52% above the 20-day moving average and near the upper end of the one-month range.

31 jul 2026, 23:01 UTC

Abbott Laboratories shares are modestly higher in after-market trading. The stock remains elevated, 7.16% above its 20-day moving average.

30 jul 2026, 23:51 UTC

Abbott Laboratories shares are higher in after-market trading, recovering from earlier losses. The stock trades significantly above its 20-day moving average.

29 jul 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours, continuing recent volatility amid mixed global market performance and rising geopolitical tensions in the Middle East.

28 jul 2026, 23:02 UTC

Abbott Laboratories shares are higher in after-market hours, showing notable volatility post-close while remaining above the 20-day moving average. No specific news was identified.

27 jul 2026, 23:02 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified to explain the movement. Broader market sentiment may be influencing the decline.

24 jul 2026, 20:02 UTC

News

A court dismissed a shareholder lawsuit regarding Abbott Laboratories' 2022 infant formula recall, boosting market sentiment as shares trade higher with increased volume.

23 jul 2026, 23:41 UTC

Abbott Laboratories shares are lower in after-market hours amid broader market weakness, particularly in the bond market, with no specific company news identified.

22 jul 2026, 22:06 UTC

Abbott Laboratories shares are higher in after-market trading, positioned above their 20-day moving average and near the upper end of their one-month trading range.

21 jul 2026, 19:01 UTC

Abbott Laboratories is lower today, continuing a decline that began Monday. The stock has dropped from an early peak amid no specific news.

20 jul 2026, 23:06 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified. Broader market volatility stems from rising Treasury yields and geopolitical tensions.

Peer Vergelijking

Prijswijziging

Abbott Laboratories Prognose

Koersdoel

By TipRanks

12.16% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 120.15 USD 12.16%

Hoogste 135 USD

Laagste 112 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor Abbott Laboratories - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

15 ratings

Buy

Hold

Sell

Gebaseerd op 15 analisten die aandelenratings hebben gegeven aan Abbott Laboratories - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

48 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.